>15
2026
影响因子区间
—
平台估算
23%
2025
中国作者发文占比
—
收费
期刊简介:Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.
【译文】《肿瘤学年鉴》是欧洲医学肿瘤学会和日本医学肿瘤学会的期刊,提供关于创新癌症治疗或与肿瘤学和精准医学相关的转化工作的快速和高效的同行评审出版物。主要关注领域包括:系统性抗癌治疗(特别关注分子靶向药物和新的免疫疗法)、随机试验(包括阴性试验)、顶级指南,以及作为个性化医学关键组成部分的新兴领域,如分子病理学、生物信息学、现代统计学和生物技术。如果放射治疗、手术和儿科稿件与上述领域之一有明确的相互作用或具有范式转变,则可以考虑。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | >15 | 暂无 |